This paper presents a research proposal for a qualitative systematic review examining the prevalence and effects of Alzheimer's Disease (AD) among American women aged 65 and older. The study identifies a significant health equity gap: although women account for two-thirds of all AD diagnoses in the United States, many cases remain undiagnosed. The paper outlines key demographic and biological risk factors — including age, hormonal changes, genetics, and brain aging — and describes a systematic review methodology drawing on studies published between 2018 and 2022. It also details the sampling strategy, database sources, and analytical tools to be used, with the goal of identifying prevention resources and coping strategies that could improve quality of life for affected women.
The problem addressed in this study is that Alzheimer's Disease (AD) is a debilitating and progressive neurodegenerative disorder estimated to affect over 5 million women in the United States, yet recent research has shown that many cases go undiagnosed (Royse et al., 2021). This leads to significant health inequalities for American women compared with men because of their increased risk for diagnosis due to demographic factors such as age, gender, and ethnicity (de Lange, 2020; Dubal, 2020; Majoka & Schimming, 2022; Peeters et al., 2022). Research has also suggested that American women with AD experience greater disability and require more assistance than their male counterparts, which further highlights the issue of inequity in healthcare for women (Zuo & Heflin, 2022).
Given this inequity, along with the increasing prevalence of AD in the United States (de Lange, 2020), there is a critical need to understand the disproportionate impacts of the condition on American women (Peeters et al., 2022). Evidence suggests that women may be more vulnerable to the negative effects of AD due to specific risks they face, such as hormonal changes, genetics, and brain aging (de Lange, 2020; Hu et al., 2022). While two-thirds of Americans diagnosed with AD are women, women also live longer than men, and age is the greatest risk factor for AD (Mielke, 2018).
Mielke (2018) calls for additional research on sex and gender differences in the risk factors and symptoms of AD, as well as for researchers to identify modifiable risk factors for the disease. The consequences of neglecting this research are significant: women will continue to remain at elevated risk for AD, and the lack of such inquiry will result in a poorer understanding of sex differences and a diminished ability to target treatments effectively for both men and women. Ultimately, there is a need to better understand how gender may moderate the impact of the condition.
The purpose of this qualitative study — conducted as a systematic review — is to examine the prevalence and effects of Alzheimer's Disease among American women, with a focus on identifying available resources and strategies for prevention. This research will utilize a systematic review methodology to include both qualitative and quantitative studies published from 2018 to 2022, involving participants aged 65 and older, and focusing on AD. This type of review is typically used to "comment on, evaluate, extend, or develop theory, linking theory to evidence and evidence to theory" (Siddaway et al., 2019, p. 747).
"Inclusion criteria, databases, and analysis tools"
"Anticipated contributions to theory and practice"
"Cited sources and bibliography"
Always verify citation format against your institution’s current style guide requirements.